Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Nkarta Inc. NKTX

Nkarta Inc is a biopharmaceutical company developing engineered natural killer (NK) cells to fight cancer. The company is focused on leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. It is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of...


Top institutional share ownership of Nkarta Inc

Name Shares Shares % change Value Value % change
Ra Capital Management, L.p. 7,805,129 39.3% $96,159 50.8%
Price T Rowe Associates Inc /md/ 3,879,662 64.5% $47,797 78.0%
NEA Management Company, LLC 3,571,640 23.0% $44,003 33.1%
Samsara BioCapital, LLC 2,868,035 41.0% $35,334 52.6%
Deep Track Capital, LP 2,814,844 33.2% $34,679 44.2%
BlackRock Inc. 2,258,662 80.2% $27,827 95.0%
Novo Holdings A/S 2,180,000 -22.0% $26,858 -15.5%
Wasatch Advisors Inc 1,631,985 93.8% $20,106 109.8%
Avidity Partners Management LP 1,414,082 $17,421
State Street Corp 1,359,615 392.1% $16,750 432.8%

Top institutional buyers of Nkarta Inc

Name Shares % change Value % change Shares Value
Fmr Llc 523829.2% 542100.0% 880,201 $10,844
FBIOX - Biotechnology Portfolio 1763.9% 1592.7% 879,766 $12,695
Two Sigma Investments, Lp 1081.1% 1179.8% 370,880 $4,569
PRSVX - T. Rowe Price Small-Cap Value Fund, Inc. 453.9% 310.7% 835,200 $9,505
State Street Corp 392.1% 432.8% 1,359,615 $16,750
Geode Capital Management, Llc 112.8% 130.4% 540,999 $6,665
Vanguard Group Inc 112.4% 129.9% 1,333,110 $16,424
Wasatch Advisors Inc 93.8% 109.8% 1,631,985 $20,106
BlackRock Inc. 80.2% 95.0% 2,258,662 $27,827
Renaissance Technologies Llc 73.3% 87.7% 405,600 $4,997

Top institutional sellers of Nkarta Inc

Name Shares % change Value % change Shares Value
Morgan Stanley -31.6% -26.0% 405,411 $4,996
Novo Holdings A/S -22.0% -15.5% 2,180,000 $26,858

Information provided by Fintel.io